{"id":"W4391302045","doi":"10.1200/jco.2024.42.4_suppl.105","title":"Patient-reported outcomes (PRO) in patients (pts) with <i>BRCA1/2</i>-altered metastatic castration-resistant prostate cancer (mCRPC) receiving niraparib (NIRA) with abiraterone acetate and prednisone (AAP): Results from MAGNITUDE study.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Abiraterone acetate; Prostate cancer; Prednisone; Abiraterone; Internal medicine; Oncology; Cancer; Castration; Androgen deprivation therapy; Hormone; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001414,0.0003734172,0.0008630481,0.0002763267,0.0001706585,0.0003649997,0.0002685182,0.000355158,0.0009477197],"category_scores_gemma":[0.00126262,0.0001797472,0.001007147,0.0004642542,0.0002541906,0.000350706,0.0003243524,0.0007321506,0.0001205068],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003191239,"about_ca_system_score_gemma":0.0003003665,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003422386,"about_ca_topic_score_gemma":0.0007365773,"domain_scores_codex":[0.9994314,0.0003311229,0.00004485469,0.000065762,0.00007485122,0.00005206138],"domain_scores_gemma":[0.9988412,0.0002513103,0.0005451835,0.00005071592,0.00004779114,0.000263836],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5804734,0.01104385,0.3122036,0.000988542,0.003923531,0.0002368199,0.0002305565,0.002176721,0.01280837,0.0001398258,0.001087559,0.07468715],"study_design_scores_gemma":[0.06625878,0.2966192,0.6287581,0.00005662884,0.002680854,0.0004094019,0.000117753,0.001522153,0.001954671,0.0001688253,0.001418832,0.00003479524],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9982454,0.0008817918,0.00009835396,0.00004857761,0.000009151091,0.0001206875,0.0003230976,0.000004871574,0.0002680709],"genre_scores_gemma":[0.9986159,0.000285967,0.0002120745,0.0000732578,0.00003230247,0.0001670363,0.0004980302,0.000001313865,0.0001141595],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001414,"threshold_uncertainty_score":0.007478058,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09669820922149745,"score_gpt":0.4317309454260764,"score_spread":0.3350327362045789,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}